Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion type Assertion NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_head.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion description "[There was a significant correlation between sustained clinical remission in additional patients with RRP and reduced levels of CCL17 (p = 0.01), CCL22 (p = 0.002) and CCL18 (p = 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_provenance.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion evidence source_evidence_literature NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_provenance.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion SIO_000772 23019074 NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_provenance.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion wasDerivedFrom befree-2016 NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_provenance.
- NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_assertion wasGeneratedBy ECO_0000203 NP1016201.RAiDLOaRPXIxpzg7D9v0R8w9lGdjtFvk35OFJbvbMoxFs130_provenance.